
Elige tu etiqueta
se ve directamente en el vialInforme de laboratorio
PDF- Analizado
- Thymosin Alpha-1 5mg
- Laboratorio
- Analiza Białek
- Fecha
- November 2026
- Resultado
- 99% purity (5.33 mg measured)
- Endotoxinas
- 4.56 EU/vial
- N.º de pedido
- Contraseña
Analizado de forma independiente, verificable con la contraseña directamente en el laboratorio.
Thymosin Alpha-1
Immune System
- Analizado en laboratorio · 99% de pureza
- Envío desde Alemania
Pedido
- DHL con seguimiento
- Embalaje discreto
De un vistazo
Thymosin Alpha-1 en cifras
Las cifras clave de nuestra enciclopedia.
Entrada completa de la enciclopedia- Class
- Immune-modulating peptidethymus-derived
- Frequency
- ~2x per weekin phases
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
The source in the lexiconRandomized controlled study of thymosin alpha-1 in severe sepsis (ETASS) (opens in a new tab)
Wu et al., Critical Care, 2013
Reseñas
Lo que dicen los clientes
Solo pedidos reales que incluían Thymosin Alpha-1.
Todas las reseñasConocimiento
Todo sobre Thymosin Alpha-1
Información detallada próximamente.
Dosificación
Cargando información de dosificación …
Conviene tenerlo
Lo que necesitas con ello
El agua bacteriostática se añade automáticamente a tu carrito. Jeringas y toallitas con un clic.
Jeringas de insulina
10 uds. · 5.50 €
Toallitas con alcohol
50 uds. · 10 €
¿Cuánta agua?
Unidades en la jeringa para tu tamaño de vial.
Abrir calculadora →Is Thymosin Alpha-1 approved?
Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.
How does Thymosin Alpha-1 work?
In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.
What do the sepsis trials show?
In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.
Are there data on cancer?
In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.
Does it help in severe pancreatitis?
Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.
Which side effects are known?
In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.
Relacionados
Productos relacionados
Thymalin
Péptidos · Sistema inmunitario Sistema inmunitario
2 tamaños
= desde 16 €/vial
KPV
Péptidos · Sistema inmunitario Sistema inmunitario
4 tamaños
Analizado en laboratorio
= desde 11.6 €/vial
VIP
Péptidos · Sistema inmunitario Sistema inmunitario
2 tamaños
= desde 23.2 €/vial
VIP Nasal
Péptidos · Sistema inmunitario Sistema inmunitario
1 tamaño
Thymosin Alpha-1